Ad
related to: moderna vaccine
Search results
Moderna's RSV vaccine for older adults approved
Axios· 6 days agoWhy it matters: It's Moderna's second approved product, and company officials said it's the first mRNA vaccine approved for a disease other than COVID-19...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
WKBT La Crosse· 1 day agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 3 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 6 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
The Joplin Globe· 13 hours agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support ...
US FDA approves Moderna's RSV vaccine with lower-than-expected efficacy in its label
AOL· 6 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus (RSV) vaccine, the company announced on Friday, giving it a shot at much-needed ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 2 days agoRepresentatives from Moderna, Pfizer-BioNtech, and Novavax presented data about the protection...
Moderna Drug Candidate Tapped for FDA Rare-Disease Pilot Program
Morningstar· 13 hours agoBy Colin Kellaher Moderna's mRNA-3705 drug candidate for a rare, genetic disorder of the liver has been chosen for a Food and Drug Administration pilot program aimed at addressing ...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 1 day agoThe Food and Drug Administration (FDA) has approved mRESVIA, a new vaccine made by Moderna, to help...
Novavax, With A 369% Gain, Reverses Bullish Gains After Key FDA Move
Investor's Business Daily· 5 hours agoThe vaccine is based on protein technology, which is appealing to people hesitant to use the newer...